Sasol Ltd
Change company Symbol lookup
Select an option...
SASOF Sasol Ltd
SMBC Southern Missouri Bancorp Inc
ALG Alamo Group Inc
AFFCF American Future Fuel Corp
TDS-U Telephone and Data Systems Inc
FRSH Freshworks Inc
TA Travelcenters of America Inc
WWW Wolverine World Wide Inc
$PABEZ5T Bloomberg PAB Eurozone 50 Decrement
CXW CoreCivic Inc
Go


Based in South Africa
Company profile

Sasol Limited is a global chemicals and energy company. The Company segment include Energy Business, Chemical Business, and Corporate Centre. The Company's Energy business includes Mining, Gas, and Fuels. Its Chemical Business includes Chemicals Africa, Chemicals America, and Chemicals Eurasia. Its Chemicals Business division includes Advanced Materials, which includes specialty aluminas, carbon and cobalt catalyst; Base Chemicals includes inter alia, monomers, polymers, nitrates, phenolics, ammonia, mono-ethylene glycol (MEG) and methanol that feature in end-uses such as agriculture, textiles and piping; Essential Care Chemicals offers a portfolio of integrated alcohols and surfactants; and Performance Solutions includes solvents, comonomers and specialty chemicals complements.

Closing Price
$17.36
Day's Change
0.00 (0.00%)
Bid
--
Ask
--
B/A Size
--
Day's High
--
Day's Low
--
Volume
(Heavy Day)
Volume:
25,647

10-day average volume:
9,003
25,647

Viatris Inc. to Participate in BofA Global Research Global Healthcare Conference

6:59 am ET September 6, 2022 (PR Newswire) Print

Viatris Inc. (NASDAQ: VTRS), a global pharmaceutical company, today announced the company will participate in the BofA Global Research Global Healthcare Conference in London on Thursday, September 15, 2022. Chief Executive Officer Michael Goettler, President Rajiv Malik and Chief Financial Officer Sanjeev Narula will represent the company in a fireside chat scheduled at 4:45 p.m. BST / 11:45 a.m. ET.

Interested parties can access a live webcast of the event at investor.viatris.com. An archived version also will be available following the live event and can be accessed at the same location for a limited time.

About Viatris

Viatris Inc. (NASDAQ: VTRS), is a global pharmaceutical company empowering people worldwide to live healthier at every stage of life. We provide access to medicines, advance sustainable operations, develop innovative solutions and leverage our collective expertise to connect more people to more products and services through our one-of-a-kind Global Healthcare Gateway(R). Formed in November 2020, Viatris brings together scientific, manufacturing and distribution expertise with proven regulatory, medical, and commercial capabilities to deliver high-quality medicines to patients in more than 165 countries and territories. Viatris' portfolio comprises more than 1,400 approved molecules across a wide range of therapeutic areas, spanning both non-communicable and infectious diseases, including globally recognized brands, complex generic and branded medicines, a portfolio of biosimilars and a variety of over-the-counter consumer products. With approximately 37,000 colleagues globally, Viatris is headquartered in the U.S., with global centers in Pittsburgh, Shanghai and Hyderabad, India. Learn more at viatris.com and investor.viatris.com, and connect with us on Twitter at @ViatrisInc, LinkedIn and YouTube.

https://mma.prnewswire.com/media/1499164/logo_Logo.jpg

https://c212.net/c/img/favicon.png?sn=NE63475&sd=2022-09-06

View original content to download multimedia:https://www.prnewswire.com/news-releases/viatris-inc-to-participate-in-bofa-global-research-global-healthcare-conference-301617944.html

SOURCE Viatris Inc.

https://rt.prnewswire.com/rt.gif?NewsItemId=NE63475&Transmission_Id=202209060659PR_NEWS_USPR_____NE63475&DateId=20220906

comtex tracking

COMTEX_413835849/1005/2022-09-06T06:59:09

Earnings Calendar and Events Data provided by |Terms of Use| © 2022 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

Information and news provided by ,, , Computrade Systems, Inc., ,, and

Copyright © 2022. All rights reserved.